BioSpace News Archive

Enables Expanded Access to the Company’s Portfolio of Tests

Wize Pharma, Inc. (“Wize Pharma” or the “Company”) (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, is pleased to announce that Mr. Mark Sieczkarek has been appointed Chairman of Wize Pharma’s Board of Directors, replacing Mr. Noam Danenberg, who will become the Company’s Chief Executive Officer, effective April 23, 2019.

Ivantis Inc., developer of the Hydrus® Microstent, announced today that the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS) were accepted into the journal Ophthalmology.

Digital manufacturing company Protolabs (NYSE: PRLB) and the Cleveland Clinic Healthcare Innovations Alliance — a network of healthcare organizations, corporations and universities focused on healthcare innovation — are collaborating on an awards program to help move novel healthcare ideas forward.

Members Convene at Company Laboratory for First Meeting

Suicide rates have steadily increased in the past two years throughout the United States, while the number of treatment centers for primary mental health diagnosis has remained stagnant.

Perforce Software, a provider of solutions to enterprise teams requiring productivity, visibility, security, and scale along the development lifecycle, released the results of a global survey of medical device professionals today.

iData Research reports notable growth is happening in the $3.6 billion dollar U.S. market, as well as the just over $600 million dollar European market.

Students around the country recognized for revolutionary solutions to women’s health, food waste, transportation systems, and improving mobility and communication for people with disabilities.

California-based Company to Provide the Nonprofit with an Ongoing Supply of Training Treats